Portola Pharmaceuticals, Inc. (NASDAQ:PTLA)

About the company

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

408

CEO

J. Scott Garland

Exchange

NASDAQ

Website

http://www.portola.com

$121.00M

Total Revenue

408

Employees

$1B

Market Capitalization

-4.77

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$79M

Operating Margin (in %)

Total operating margin

$-256M

Net Margin (in %)

Total net margin

$-282M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11671.80 1376.00 4.98 18.40 43.06
Catalent, Inc. CTLT 10932.13 2872.00 5.49 104.81 3.63
Perrigo Co. Plc PRGO 7571.99 4837.00 1.30 51.65 3.02
Bausch Health Cos., Inc. BHC 6456.37 8597.00 9.01 -3.41 -21.96
Jazz Pharmaceuticals Plc JAZZ 6247.77 2188.00 2.16 22.84 12.81
United Therapeutics Corp. UTHR 5203.00 1443.00 1.81 10.04 36.59
MyoKardia, Inc. MYOK 4444.52 34.00 12.92 -14.34 -201.73
Axsome Therapeutics, Inc. AXSM 2672.60 None 18.14 -29.71 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2231.88 435.00 5.98 -5314.00 -0.02
SAGE Therapeutics, Inc. SAGE 2162.16 9.00 2.54 -3.34 -413.06
Corcept Therapeutics, Inc. CORT 2084.98 335.00 4.79 19.64 31.64
Revolution Medicines, Inc. RVMD 1920.45 48.00 4.98 -27.12 -146.29
Prestige Consumer Healthcare, Inc. PBH 1907.40 963.00 1.60 13.45 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1765.35 0.00 4.71 -17.28 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1620.24 440.00 -22.93 19.11 19.14
Innoviva, Inc. INVA 1574.09 285.00 3.72 8.15 66.41
Intercept Pharmaceuticals, Inc. ICPT 1476.16 272.00 -43.93 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1308.15 5.00 3.57 -3.08 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1254.96 402.00 1.99 10.76 28.90
Theravance Biopharma, Inc. TBPH 1196.43 88.00 -8.40 -4.85 -280.80
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1100.54 327.00 2.75 21.60 15.90
Endo International Plc ENDP 800.28 3014.00 -1.09 -2.85 -9.09
BellRing Brands, Inc. BRBR 764.79 954.00 -0.41 5.80 13.98
Aerie Pharmaceuticals, Inc. AERI 678.96 79.00 5.39 -3.35 -252.92
Assembly Biosciences, Inc. ASMB 676.28 16.00 3.03 -6.80 -601.75
Eagle Pharmaceuticals, Inc. EGRX 671.72 192.00 3.61 266.56 1.29
Collegium Pharmaceutical, Inc. COLL 590.58 299.00 4.23 -45.71 -4.21
Anika Therapeutics, Inc. ANIK 539.98 125.00 1.87 19.48 22.73
Catalyst Pharmaceuticals, Inc. CPRX 487.92 119.00 4.75 11.12 36.09
Intersect ENT, Inc. XENT 411.20 102.00 3.88 -8.24 -48.61
BioDelivery Sciences International, Inc. BDSI 405.26 130.00 5.80 -55.06 -5.01
ANI Pharmaceuticals, Inc. ANIP 391.32 203.00 2.00 -250.85 -0.67
MEI Pharma, Inc. MEIP 356.90 5.00 6.14 -9.15 -539.48
Albireo Pharma, Inc. ALBO 344.37 11.00 3.50 -4.51 -730.55
Mallinckrodt Plc MNK 233.52 3037.00 0.12 -0.19 -39.56
Marinus Pharmaceuticals, Inc. MRNS 168.21 0.00 6.51 -2.50 None
Agile Therapeutics, Inc. AGRX 164.02 None 2.67 -7.94 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 97.81 1.00 68.40 -5.26 None
AcelRx Pharmaceuticals, Inc. ACRX 94.40 2.00 -1.74 -1.69 -644.25
Evoke Pharma, Inc. EVOK 84.96 None 29.50 -12.64 None
Adamas Pharmaceuticals, Inc. ADMS 70.28 57.00 -4.48 -0.76 -160.44
CTI BioPharma Corp. CTIC 68.44 3.00 3.05 -1.66 -111.83
Aclaris Therapeutics, Inc. ACRS 66.42 4.00 1.17 -0.48 None
Oramed Pharmaceuticals, Inc. ORMP 63.54 3.00 5.12 -4.97 -464.15
Cassava Sciences, Inc. SAVA 56.81 41.00 2.99 -12.46 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.95 47.00 1.02 -11.10 -9.59
SCYNEXIS, Inc. SCYX 49.93 0.00 10.49 -1.29 -30.84
Natural Alternatives International, Inc. NAII 48.37 114.00 0.66 -12.80 -3.19
Lipocine, Inc. LPCN 37.80 0.00 9.00 -2.52 None
IsoRay, Inc. ISR 37.77 9.00 7.05 -11.27 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.25 65.00 -2.63 -1.96 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.61 3.00 2.44 -1.66 -264.21
Regulus Therapeutics, Inc. RGLS 14.91 0.00 1.31 -0.70 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.60 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.87 None 1.40 -0.25 None
VIVUS, Inc. VVUS 9.02 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 7.12 19.00 1.13 -2.28 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.42 None 1.69 -0.46 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.36 None 1.09 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Portola Pharmaceuticals Inc (PTLA): Hedge Funds Are Cashing Out

7d ago, source: YAHOO!

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will ...

Portola Investor Wants Docs About $1.4B Alexion Deal

7h ago, source: Law360

A Portola Pharmaceuticals investor filed a lawsuit Tuesday in Delaware Chancery Court seeking records from the biotech company to probe possible wrongdoing related to its proposed $1.4 billion ...

Portola Pharmaceuticals Inc.

12d ago, source: MarketWatch

09/18/2015 978 Derivative/Non-derivative trans. at $5.1 per share. 4,987 ...

Portola Pharmaceuticals (PTLA) Stock

5d ago, source: Business Insider

2020 Insider Inc. and finanzen.net GmbH All rights ... Made In NYC | Stock quotes by finanzen.net GO IN-DEPTH ON Portola Pharmaceuticals STOCK Portola Pharmaceuticals NewsMORE Quotes for Portola ...

Portola Pharmaceuticals (NASDAQ:PTLA) Downgraded to Sell at BidaskClub

9d ago, source: modernreaders.com

BidaskClub lowered shares of Portola Pharmaceuticals (NASDAQ:PTLA) from a hold rating to a sell rating in a research report ...

Rigrodsky & Long, P.A. Files Class Action Suit Against Portola Pharmaceuticals, Inc.

14d ago, source: MarketWatch

Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals Inc.

6d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.